Oxford Instruments' profit up 22% in fiscal 1996
This article was originally published in Clinica
UK company Oxford Instruments reported net profit of £13.6 million ($21 million) in fiscal 1996, up 22% on last year, on turnover of £146.3 million, up 17%. New orders for the year, ended March 31st, 1996, increased 15% to £151 million. Exports and overseas sales accounted for more than 85% of output.
You may also be interested in...
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.